# A Noninterventional, Single-Center Feasibility Study to Evaluate Measures of Heart Failure Risk

> **NCT05646056** · — · COMPLETED · sponsor: **Prolaio** · enrollment: 82 (actual)

## Conditions studied

- Heart Failure
- Cardiomyopathy, Hypertrophic
- Left Ventricular Hypertrophy

## Interventions

- **DEVICE:** Software

## Key facts

- **NCT ID:** NCT05646056
- **Lead sponsor:** Prolaio
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-28
- **Primary completion:** 2024-09-18
- **Final completion:** 2024-09-18
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2024-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05646056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05646056, "A Noninterventional, Single-Center Feasibility Study to Evaluate Measures of Heart Failure Risk". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05646056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*